Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Humana Inc.    HUM

HUMANA INC.

(HUM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Humana Inc. : The underlying trend is to the upside

share with twitter share with LinkedIn share with facebook
10/15/2020 | 10:16am EDT
long trade
Target price hit
Entry price : 424.51$ | Target : 433$ | Stop-loss : 391$ | Potential : 2%
The timing appears opportune to go long in shares of Humana Inc. as we anticipate another pick-up in the underlying trend.
Investors have an opportunity to buy the stock and target the $ 433.
Humana Inc. : Humana Inc. : The underlying trend is to the upside
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • In a short-term perspective, the company has interesting fundamentals.

Strengths
  • Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 38% by 2022.
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
  • The stock, which is currently worth 2020 to 0.74 times its sales, is clearly overvalued in comparison with peers.
  • For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The tendency within the weekly time frame is positive above the technical support level at 319.68 USD

Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at USD 433.44.
  • Technically, the stock approaches a strong medium-term resistance at USD 433.44.
  • The company is not the most generous with respect to shareholders' compensation.


share with twitter share with LinkedIn share with facebook

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (USD)
Sales 2020 75 155 M - -
Net income 2020 2 504 M - -
Net Debt 2020 1,56 M - -
P/E ratio 2020 23,7x
Yield 2020 0,56%
Capitalization 58 779 M 58 779 M -
EV / Sales 2020 0,78x
EV / Sales 2021 0,71x
Nbr of Employees 46 000
Free-Float 66,4%
Upcoming event on HUMANA INC.
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 454,28 $
Last Close Price 444,31 $
Spread / Highest target 20,2%
Spread / Average Target 2,24%
Spread / Lowest Target -11,1%
EPS Revisions
Managers
NameTitle
Bruce Dale Broussard President, Chief Executive Officer & Director
Kurt J. Hilzinger Chairman
Brian A. Kane Chief Financial Officer & Senior Vice President
Brian P. LeClaire Chief Information Officer & Senior Vice President
Sam Deshpande SVP, Chief Risk & Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
HUMANA INC.21.22%58 779
UNITEDHEALTH GROUP12.46%314 181
ANTHEM, INC.2.89%78 158
CIGNA CORPORATION-9.78%67 745
CENTENE CORPORATION7.24%39 068
MOLINA HEALTHCARE, INC.56.64%12 604